World's Best Scientists 2026 revealed!
Peter Verhamme

Peter Verhamme

D-Index & Metrics

Medicine

D-Index
80
Citations
47455
World Ranking
16865
National Ranking
210

Peter Verhamme publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Peter Verhamme sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 574 publications — 69th percentile

69% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Peter Verhamme D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Peter Verhamme sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 80 D-Index — 16th percentile

16% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Peter Verhamme is affiliated with KU Leuven in Belgium and has a research focus primarily in the field of Medicine. Their work spans several subfields, including Cardiology and Cardiovascular Medicine, Internal Medicine, Infectious Diseases, Surgery, and Hematology.

The main topics addressed in their research include:

  • Venous Thromboembolism Diagnosis and Management
  • Atrial Fibrillation Management and Outcomes
  • COVID-19 Clinical Research Studies
  • Blood Coagulation and Thrombosis Mechanisms
  • Antiplatelet Therapy and Cardiovascular Diseases
  • Blood Pressure and Hypertension Studies
  • Acute Ischemic Stroke Management

Verhamme has published extensively, with frequent contributions to several key journals such as:

  • Journal of Hypertension
  • European Heart Journal
  • Journal of Thrombosis and Haemostasis
  • Research and Practice in Thrombosis and Haemostasis
  • Thrombosis Research

Frequently collaborating with other researchers, common coauthors include:

  • Thomas Vanassche
  • Jan A. Staessen
  • Jesús D. Melgarejo
  • Zhen-Yu Zhang
  • Stefan Janssens

Selected recent papers by Peter Verhamme include:

  • Abelacimab for Prevention of Venous Thromboembolism, 2021, New England Journal of Medicine
  • American Society of Hematology 2020 Guidelines for Management of Venous Thromboembolism: Treatment of Deep Vein Thrombosis and Pulmonary Embolism, 2020, Blood Advances
  • Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 study, 2022, The Lancet
  • Andexanet for Factor Xa Inhibitor-Associated Acute Intracerebral Hemorrhage, 2024, New England Journal of Medicine
  • Role of Combination Antiplatelet and Anticoagulation Therapy in Diabetes Mellitus and Cardiovascular Disease, 2020, Circulation

Best Publications

  • Oral rivaroxaban for symptomatic venous thromboembolism

    Rupert Bauersachs;Scott D. Berkowitz;Benjamin Brenner;Harry R. Buller

  • Oral Rivaroxaban for the Treatment of Symptomatic Pulmonary Embolism

    Barry F. Jacobson;Erich Minar;Jaromir Chlumsky;Peter Verhamme

  • Edoxaban versus Warfarin for the Treatment of Symptomatic Venous Thromboembolism

    Harry R. Büller;Hervé Décousus;Michael A. Grosso;Saskia Middeldorp

  • Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease

    John W. Eikelboom;Stuart J. Connolly;Jackie Bosch;Gilles R. Dagenais

  • The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation.

    Steffel J;Verhamme P;Potpara Ts;Albaladejo P

  • Idarucizumab for Dabigatran Reversal

    Charles V. Pollack;Paul A. Reilly;John Eikelboom;Stephan Glund

  • Updated European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist anticoagulants in patients with non-valvular atrial fibrillation.

    Hein Heidbuchel;Peter Verhamme;Marco Alings;Matthias Antz

  • Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism

    Gary E. Raskob;Nick van Es;Peter Verhamme;Marc Carrier

  • European Heart Rhythm Association Practical Guide on the use of new oral anticoagulants in patients with non-valvular atrial fibrillation

    Hein Heidbuchel;Peter Verhamme;Marco Alings;Matthias Antz

  • Idarucizumab for Dabigatran Reversal — Full Cohort Analysis

    Charles V. Pollack;Paul A. Reilly;Joanne van Ryn;John W. Eikelboom

  • American Society of Hematology 2020 guidelines for management of venous thromboembolism: treatment of deep vein thrombosis and pulmonary embolism.

    Thomas L. Ortel;Ignacio Neumann;Walter Ageno;Rebecca Beyth;Rebecca Beyth

  • Andexanet Alfa for Acute Major Bleeding Associated with Factor Xa Inhibitors

    Stuart J. Connolly;Truman J. Milling;John W. Eikelboom;C. Michael Gibson

  • Full Study Report of Andexanet Alfa for Bleeding Associated with Factor Xa Inhibitors

    Stuart J. Connolly;Mark Crowther;John W. Eikelboom;C. Michael Gibson

  • Rivaroxaban or Aspirin for Extended Treatment of Venous Thromboembolism

    Jeffrey I. Weitz;Anthonie W.A. Lensing;Martin H. Prins;Rupert Bauersachs

  • Circulating Oxidized LDL Is a Useful Marker for Identifying Patients With Coronary Artery Disease

    Paul Holvoet;Ann Mertens;Peter Verhamme;Kris Bogaerts

  • Outpatient versus inpatient treatment for patients with acute pulmonary embolism : an international, open-label, randomised, non-inferiority trial.

    Drahomir Aujesky;Pierre-Marie Roy;Franck Verschuren;Marc Philip Righini

  • Factor XI Antisense Oligonucleotide for Prevention of Venous Thrombosis

    Harry Roger Buller;Claudette Bethune;Sanjay Bhanot;David Gailani

  • EHRA Practical Guide on the use of new oral anticoagulants in patients with non-valvular atrial fibrillation : executive summary

    Hein Heidbuchel;Peter Verhamme;Marco Alings;Matthias Antz

  • Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism

    G.E. Raskob;N. van Es;P. Verhamme;M. Carrier

  • European Heart Rhythm Association Practical G u i d eo nt h e u s eo fn e w o r a l a n t i c o a g u l a n t s i n patients with non-valvular atrial fibrillation

    Hein Heidbuchel;Peter Verhamme;Marco Alings;Matthias Antz

Frequent Co-Authors

Walter Ageno
Walter Ageno University of Insubria
John W. Eikelboom
John W. Eikelboom Population Health Research Institute
Jeffrey I. Weitz
Jeffrey I. Weitz McMaster University
Paolo Prandoni
Paolo Prandoni University of Padua
Manuel Monreal
Manuel Monreal Autonomous University of Barcelona
Gary E. Raskob
Gary E. Raskob University of Oklahoma Health Sciences Center
Saskia Middeldorp
Saskia Middeldorp Radboud University Medical Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring alternative healthcare degrees online can open up new career pathways for those interested in the medical field. Many students who consider medical school also look into fast track medical programs, such as Licensed Practical Nurse (LPN) courses. These programs offer a quicker entry into patient care roles and provide valuable experience.

For those with a passion for mental health, becoming a Psychiatric Nurse Practitioner is another rewarding route. Accredited schools now provide flexible and accessible options like the psych np programs online, allowing professionals to advance their qualifications while working.

If you prefer the administrative side of healthcare, earning a Master’s in Healthcare Administration (MHA) could be the right fit. Many universities offer the cheapest mha programs online, helping students gain vital management skills without overwhelming debt. Researching cheap mha programs can help you find high-quality options that suit your budget and career goals.

Best Scientists Citing Peter Verhamme

Trending Scientists

Recently Published Articles